UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM 6-K
 

 
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
October 15, 2024
 
Commission File Number: 001-38159


 
BRITISH AMERICAN TOBACCO P.L.C.
(Translation of registrant’s name into English)


 
Globe House
4 Temple Place
London WC2R 2PG
United Kingdom
(Address of principal executive office)


 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F               Form 40-F ☐
 
 
 

 

 
This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of October 15, 2024.


EXHIBIT INDEX
 
Exhibit
 
Description
 

     
Exhibit 2
 

  


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
British American Tobacco p.l.c.
 
   
 
       
 
By:
/s/ Christopher Worlock
 
    Name: 
Christopher Worlock  
    Title:   
Assistant Secretary
 
       
 
Date:  October 15, 2024







Exhibit 1


British American Tobacco p.l.c.

15 October 2024

TRANSACTION IN OWN SHARES

British American Tobacco p.l.c. (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 24 April 2024 it purchased the following number of its ordinary shares of 25 pence each ("shares") from Goldman Sachs International as part of its buyback programme announced on 18 March 2024:

Date of purchase:
14 October 2024
Number of ordinary shares of 25 pence each purchased:
64,650
Highest price paid per share (pence):
2,696.00p
Lowest price paid per share (pence):
2,685.00p
Volume weighted average price paid per share (pence):
2,690.43p

The Company intends to cancel the purchased shares.

Following the purchase and cancellation of these shares, the Company will have 2,213,775,507 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 133,271,256 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Goldman Sachs International on 14 October 2024 is set out below.

Enquiries:

Investor Relations
Victoria Buxton: +44 (0)20 7845 2012 | IR_team@bat.com

Schedule of purchases - aggregate information

Issuer name
ISIN Code
Transaction date
Daily total volume (in number of shares)
Daily weighted average price of shares acquired
Platform
British American Tobacco p.l.c.
GB0002875804
14/10/2024
64,650
2,690.43p
LSE
British American Tobacco p.l.c.
GB0002875804
14/10/2024
0
0
CHIX
British American Tobacco p.l.c.
GB0002875804
14/10/2024
0
0
BATE




Schedule of purchases - individual transactions

Number of shares
purchased
Transaction price
(per share)
Market
Time of transaction
250
2691
XLON
08:51:49
50
2691
XLON
09:01:26
270
2691
XLON
09:01:26
1
2691
XLON
09:02:12
120
2691
XLON
09:02:18
256
2691
XLON
09:02:18
224
2692
XLON
09:04:00
276
2692
XLON
09:04:00
669
2692
XLON
09:04:43
100
2693
XLON
09:04:43
1
2692
XLON
09:06:39
284
2692
XLON
09:06:39
88
2691
XLON
09:06:39
91
2691
XLON
09:06:39
55
2691
XLON
09:06:39
13
2691
XLON
09:06:39
226
2691
XLON
09:06:39
250
2691
XLON
09:06:56
298
2691
XLON
09:08:12
250
2690
XLON
09:09:35
133
2691
XLON
09:11:12
525
2691
XLON
09:11:12
405
2692
XLON
09:13:31
429
2691
XLON
09:13:45
349
2691
XLON
09:14:47
456
2690
XLON
09:15:35
288
2690
XLON
09:16:59
267
2689
XLON
09:17:22
408
2689
XLON
09:21:10
274
2688
XLON
09:26:04
263
2689
XLON
09:26:13
271
2689
XLON
09:27:20
262
2688
XLON
09:27:54
268
2687
XLON
09:28:06
250
2686
XLON
09:28:36
273
2685
XLON
09:29:48
507
2687
XLON
09:31:02
311
2689
XLON
09:32:23
293
2688
XLON
09:32:36
352
2688
XLON
09:34:15
361
2687
XLON
09:34:41
292
2688
XLON
09:35:51
337
2687
XLON
09:37:17
315
2687
XLON
09:40:10


271
2688
XLON
09:41:35
264
2687
XLON
09:42:25
257
2690
XLON
09:45:39
251
2689
XLON
09:47:01
276
2688
XLON
09:51:00
256
2688
XLON
09:55:06
119
2687
XLON
09:55:24
140
2687
XLON
09:55:24
275
2687
XLON
09:56:37
368
2687
XLON
09:58:03
340
2688
XLON
10:04:51
323
2687
XLON
10:04:51
433
2686
XLON
10:04:51
131
2689
XLON
10:07:40
865
2689
XLON
10:07:40
768
2688
XLON
10:10:43
214
2688
XLON
10:12:59
5
2688
XLON
10:12:59
634
2689
XLON
10:15:11
268
2688
XLON
10:15:14
425
2688
XLON
10:23:25
231
2688
XLON
10:23:25
212
2687
XLON
10:26:02
547
2687
XLON
10:26:02
62
2688
XLON
10:28:00
218
2688
XLON
10:28:00
9
2688
XLON
10:31:25
1
2688
XLON
10:31:25
3
2688
XLON
10:31:25
7
2688
XLON
10:31:32
3
2688
XLON
10:31:32
285
2688
XLON
10:32:14
18
2688
XLON
10:35:24
3
2688
XLON
10:35:24
37
2688
XLON
10:35:56
193
2688
XLON
10:36:57
251
2687
XLON
10:38:11
215
2688
XLON
10:47:11
200
2688
XLON
10:50:34
253
2688
XLON
10:50:34
243
2687
XLON
10:55:00
174
2687
XLON
10:56:39
108
2689
XLON
11:04:05
851
2689
XLON
11:04:05
941
2691
XLON
11:06:13
20
2691
XLON
11:12:05
918
2691
XLON
11:12:05
929
2691
XLON
11:25:11


969
2691
XLON
11:29:03
760
2691
XLON
11:30:29
943
2690
XLON
11:32:40
78
2689
XLON
11:39:53
852
2689
XLON
11:39:53
867
2689
XLON
11:42:31
70
2690
XLON
11:51:23
923
2690
XLON
11:51:23
300
2689
XLON
11:51:39
395
2690
XLON
11:55:30
57
2690
XLON
11:55:30
203
2690
XLON
11:55:30
42
2690
XLON
11:55:30
261
2690
XLON
11:55:30
721
2690
XLON
11:55:32
231
2689
XLON
11:56:31
334
2688
XLON
11:57:08
61
2687
XLON
11:58:45
60
2687
XLON
11:58:45
50
2687
XLON
11:58:45
15
2687
XLON
11:59:14
217
2687
XLON
11:59:14
210
2688
XLON
12:00:00
18
2688
XLON
12:00:03
16
2688
XLON
12:00:07
53
2688
XLON
12:00:08
23
2688
XLON
12:00:09
104
2688
XLON
12:00:09
976
2689
XLON
12:03:54
51
2688
XLON
12:03:54
249
2688
XLON
12:03:54
300
2690
XLON
12:13:08
463
2690
XLON
12:13:08
1
2690
XLON
12:18:15
759
2690
XLON
12:18:15
206
2691
XLON
12:24:45
292
2691
XLON
12:24:45
929
2692
XLON
12:29:11
925
2694
XLON
12:30:57
934
2693
XLON
12:34:36
302
2692
XLON
12:34:40
192
2692
XLON
12:34:40
457
2692
XLON
12:34:40
92
2691
XLON
12:37:25
940
2693
XLON
12:49:28
971
2692
XLON
12:51:02
925
2693
XLON
13:01:37
199
2692
XLON
13:04:49


26
2692
XLON
13:04:49
742
2692
XLON
13:08:33
59
2693
XLON
13:18:33
213
2693
XLON
13:18:33
101
2693
XLON
13:18:33
71
2693
XLON
13:18:33
52
2693
XLON
13:18:33
436
2693
XLON
13:18:33
7
2693
XLON
13:35:24
340
2693
XLON
13:35:24
593
2693
XLON
13:35:24
946
2692
XLON
13:39:30
980
2692
XLON
13:46:34
210
2694
XLON
13:51:35
327
2694
XLON
13:51:35
415
2694
XLON
13:51:35
148
2694
XLON
13:51:35
676
2695
XLON
13:53:57
120
2695
XLON
13:53:57
346
2695
XLON
13:57:45
123
2695
XLON
13:57:45
148
2695
XLON
13:57:45
185
2695
XLON
13:57:45
963
2694
XLON
13:58:22
58
2693
XLON
13:59:04
1
2693
XLON
13:59:04
920
2693
XLON
13:59:04
955
2692
XLON
14:01:02
996
2691
XLON
14:01:53
116
2690
XLON
14:02:16
841
2690
XLON
14:02:16
898
2689
XLON
14:06:23
943
2692
XLON
14:16:42
941
2691
XLON
14:21:17
34
2691
XLON
14:30:05
393
2691
XLON
14:30:05
777
2690
XLON
14:30:33
713
2689
XLON
14:30:39
258
2690
XLON
14:31:01
1744
2690
XLON
14:31:01
218
2690
XLON
14:31:18
495
2690
XLON
14:31:18
124
2696
XLON
15:02:19
3
2696
XLON
15:02:22
239
2696
XLON
15:02:22
133
2696
XLON
15:02:22
1
2696
XLON
15:02:22
88
2696
XLON
15:04:10


12
2696
XLON
15:04:10
50
2695
XLON
15:06:38

Exhibit 2


 
 

15 October 2024


BAT Capital Markets Day

On 16 October 2024, we will host a Capital Markets Day for institutional investors and analysts at our Innovation Centre in Southampton, UK. Chief Executive, Tadeu Marroco, and Chief Financial Officer, Soraya Benchikh, will be joined by the management team and senior leaders from across the Group to provide further detail on our transformation journey.

We are committed to Building a Smokeless World and becoming a predominantly smokeless1 business by 2035. By providing smokers with access to a wide range of smokeless products, we can drive forward Tobacco Harm Reduction and, ultimately, make cigarettes a thing of the past.

Our well-established multi-category strategy, global footprint, and deep consumer insights are crucial drivers of this journey. Our latest Innovation Centre in Southampton, opened earlier this year, is home to many of our 1,750 scientists, who deliver the rigorous science and R&D that underpin our New Categories.

This event will demonstrate how BAT’s science, innovation, breadth of capabilities and people can combine to achieve a Smokeless World and deliver long-term sustainable value for all our stakeholders.

On track for full-year 2024 guidance

We remain on track to deliver low-single digit organic revenue and adjusted profit from operations growth in FY24. We will progressively improve our delivery to 3-5% organic revenue growth, and mid-single figure adjusted profit from operations growth, on an organic, constant currency basis2 by 2026.  

Extrapolating current spot rates3, we anticipate currency translation to be a c.5% headwind on FY24 adjusted profit from operations. All other guidance is unchanged.

Event details

Presentations will start at 8:30am on 16 October 2024. There will also be a live webcast on www.bat.com/ir for attendees who wish to join the event virtually. A copy of the presentations, together with a video playback of the webcast, will be made available after the event via the same link, and on our refreshed BAT IR App.

For further information, please contact:

Media Centre
+44 (0) 20 7845 2888 (24 hours) | press_office@bat.com @BATplc

Investor Relations
Victoria Buxton: +44 (0)20 7845 2012
Amy Chamberlain: +44 (0)20 7845 1124
John Harney: +44 (0)20 7845 1263
ir_team@bat.com

Notes:

1 Predominantly smokeless refers to our ambition to achieve 50% of Group revenue from our smokeless products by 2035. Smokeless refers to Non-Combustibles, including Vapour products, Heated Products, Modern Oral pouches and Traditional Oral.

2 To supplement the Group's results presented in accordance with International Financial Reporting Standards (IFRS), the Group's Management Board, as the chief operating decision maker, reviews certain of its results, including revenue, and adjusted profit from operations, at constant rates of exchange, prior to the impact of businesses sold or held-for-sale in the case of revenue and adjusted profit from operations. Although the Group does not believe that these measures are a substitute for IFRS or other operating measures, the Group does believe that such results excluding the impact of businesses sold or to be held-for-sale provide additional useful information to investors regarding the underlying performance of the business on a comparable basis and in the case of the sale of the Group's businesses in Russia and Belarus, the impact these businesses had on revenue and profit from operations. Accordingly, the organic volume and financial measures appearing in this document should be read in conjunction with the Group's results as reported under IFRS and other operating measures.

3 Based on current exchange rates of USD/GBP 1.3075 as at close on 11 October 2024.







 
Important information

References in this announcement to ‘BAT’, ‘Group’, ‘we’, ‘us’ and ‘our’ when denoting opinion refer to British American Tobacco p.l.c. (BAT PLC) and when denoting business activity refer to BAT Group operating companies, collectively or individually as the case may be. This announcement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any BAT PLC shares or other securities.

Forward looking statements

This announcement contains certain forward-looking statements, including “forward-looking” statements made within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use of words or phrases such as “believe,” “anticipate,” “could,” “may,” “would,” “should,” “intend,” “plan,” “potential,” “predict,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “outlook”, “target” and similar expressions. These include statements regarding our intentions, beliefs or current expectations concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which the Group operates.

In particular, these forward-looking statements include statements regarding (i) our commitment to Building a Smokeless World and becoming a predominantly smokeless business by 2035 and (ii) statements under the heading “On track for full-year 2024 guidance.”

All such forward-looking statements involve estimates and assumptions that are subject to risks, uncertainties and other factors. It is believed that the expectations reflected in this announcement are reasonable but they may be affected by a wide range of variables that could cause actual results and performance to differ materially from those currently anticipated.

Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are uncertainties related to the following: the impact of competition from illicit trade; the impact of adverse domestic or international legislation and regulation; the inability to develop, commercialise and deliver the Group's New Categories strategy; the impact of supply chain disruptions; adverse litigation and dispute outcomes and the effect of such outcomes on the Group's financial condition; the impact of significant increases or structural changes in tobacco, nicotine and New Categories related taxes; translational and transactional foreign exchange rate exposure; changes or differences in domestic or international economic or political conditions; the ability to maintain credit ratings and to fund the business under the current capital structure; the impact of serious injury, illness or death in the workplace; adverse decisions by domestic or international regulatory bodies; changes in the market position, businesses, financial condition, results of operations or prospects of the Group; direct or indirect adverse impacts associated with climate change and the move towards a circular economy; and cyber security risks caused by the heightened cyber-threat landscape, and increased digital interactions with consumers, and changes to regulation.

Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and BAT undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on such forward-looking statements.

No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per share of BAT PLC for the current or future financial years would necessarily match or exceed the historical published earnings per share of BAT PLC.

Additional information concerning these and other factors can be found in BAT PLC filings with the U.S. Securities and Exchange Commission (SEC), including the Annual Report on Form 20-F for the financial year ended December 31, 2023 and Current Reports on Form 6-K, which may be obtained free of charge at the SEC’s website, http://www.sec.gov, and at the British American Tobacco website, http://www.bat.com.







British American Tobacco (NYSE:BTI)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024 Haga Click aquí para más Gráficas British American Tobacco.
British American Tobacco (NYSE:BTI)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024 Haga Click aquí para más Gráficas British American Tobacco.